Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

The efficacy of neoadjuvant therapy (NT) versus surgery first (SF) for pancreatic ductal adenocarcinoma (PDAC) remains controversial. A random-effects meta-analysis of only prospective randomized controlled trials (RCTs) comparing NT versus SF for potentially resectable (PR) or borderline resectable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Cloyd, Jordan M., Heh, Victor, Pawlik, Timothy M., Ejaz, Aslam, Dillhoff, Mary, Tsung, Allan, Williams, Terence, Abushahin, Laith, Bridges, John F. P., Santry, Heena
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231310/
https://ncbi.nlm.nih.gov/pubmed/32326559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041129
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados